Thu, October 11, 2012
[ Thu, Oct 11th 2012 ] - Market Wire
Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants
[ Thu, Oct 11th 2012 ] - Market Wire
Solta Medical to Report Third Quarter 2012 Result .. ease and Host Conference Call on October 30, 2012
[ Thu, Oct 11th 2012 ] - Market Wire
Cytomedix Announces Presentation of ALD-401 Safety Data at the World Stroke Congress in Brazil
[ Thu, Oct 11th 2012 ] - Market Wire
Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer
[ Thu, Oct 11th 2012 ] - Market Wire
Merit Medical Systems Announces Earnings Release .. Information For The Third Quarter Ended Septembe
[ Thu, Oct 11th 2012 ] - Market Wire
Sirona Biochem Names Neil Belenkie as Chief Executive Officer
[ Thu, Oct 11th 2012 ] - Market Wire
Amerigroup Foundation Presents 'Champion for Children' Award to Texas Sen. Juan Hinojosa
[ Thu, Oct 11th 2012 ] - Market Wire
CryoLife Announces Release Date and Teleconferenc .. Details for 2012 Third Quarter Financial Results
[ Thu, Oct 11th 2012 ] - Market Wire
Thoratec Appoints Taylor C. Harris As Chief Financial Officer
[ Thu, Oct 11th 2012 ] - Market Wire
Isis Investment In Regulus Valued At $28 Million At Completion Of Regulus Initial Public Offering
[ Thu, Oct 11th 2012 ] - Market Wire
QUMAS Compliance Platform Chosen by Emergent BioS .. lutions to Manage Quality Across the Organization
[ Thu, Oct 11th 2012 ] - Market Wire
Bioheart Presents at AABB Conference in Boston
[ Thu, Oct 11th 2012 ] - Market Wire
Implant Sciences Continues Sales Into Africa for Corporate Security
[ Thu, Oct 11th 2012 ] - Market Wire
Sequenom Announces Appointment Of Bill Bowen To Senior Vice President And General Counsel
[ Thu, Oct 11th 2012 ] - Market Wire
Marina Biotech, Inc. Announces Full Year 2011 Financial Results
[ Thu, Oct 11th 2012 ] - Market Wire
Dynamic Energy Alliance Subsidiary Announces Agre .. Exclusive Worldwide License for High Value Organ
[ Thu, Oct 11th 2012 ] - Market Wire
Lilly's Fifth Global Day Of Service Focuses On Local Waterways
Wed, October 10, 2012
[ Wed, Oct 10th 2012 ] - Market Wire
MSA Schedules Third Quarter Earnings Webcast
[ Wed, Oct 10th 2012 ] - Market Wire
Universal Health Services, Inc. Completes Acquisi .. tion And Divestiture Of Auburn Regional Medical C
[ Wed, Oct 10th 2012 ] - Market Wire
CNS honored guest lecturer Dr. Ralph Dacey speaks on impact of iMRI on Oct. 10
[ Wed, Oct 10th 2012 ] - Market Wire
Levi &;; Korsinsky Notifies Investors W .. t in Questcor Pharmaceuticals, Inc. of Class Acti
[ Wed, Oct 10th 2012 ] - Market Wire
IDEXX Laboratories to Release 2012 Third Quarter Financial Results
[ Wed, Oct 10th 2012 ] - Market Wire
MiMedx Group, Inc. Announces Release Date for 2012 Third Quarter Results
[ Wed, Oct 10th 2012 ] - Market Wire
Regeneron to Report Third Quarter 2012 Financial .. t Conference Call and Webcast on October 24, 2012
[ Wed, Oct 10th 2012 ] - Market Wire
Edwards Lifesciences Acquires BMEYE
[ Wed, Oct 10th 2012 ] - Market Wire
BD Announces Chief Financial Officer Transition
[ Wed, Oct 10th 2012 ] - Market Wire
Theratechnologies Provides Follow-Up Regulatory Update on Tesamorelin
[ Wed, Oct 10th 2012 ] - Market Wire
MethylGene Provides Clinical Update on its MGCD290 Novel Antifungal Therapeutic Program
[ Wed, Oct 10th 2012 ] - Market Wire
First Patient Enrolled in REPRISE II TAVR Clinica .. afety and Performance of the Lotusa" Valve System
Tue, October 9, 2012
[ Tue, Oct 09th 2012 ] - Market Wire
Paladin Announces Agreement With QRxPharma for Novel Acute Pain Product
[ Tue, Oct 09th 2012 ] - Market Wire
Quidel to Hold Third Quarter 2012 Financial Results Conference Call on October 23, 2012
[ Tue, Oct 09th 2012 ] - Market Wire
Depomed, Inc. Appoints Dr. Samuel Saks To Its Board Of Directors
[ Tue, Oct 09th 2012 ] - Market Wire
PDL BioPharma Completes Royalty Transaction with AxoGen
[ Tue, Oct 09th 2012 ] - Market Wire
Amerigroup Announces Conference Participation for October
[ Tue, Oct 09th 2012 ] - Market Wire
Mylan Announces Settlement Agreement for its First-to-File Generic Version of Orapred ODT
[ Tue, Oct 09th 2012 ] - Market Wire
Manhattan Isotope Technology Receives Drug Master File Acknowledgment Letter From FDA
[ Tue, Oct 09th 2012 ] - Market Wire
Extendicare Announces 2012 Third Quarter Financia .. ults News Release and Conference Call Information
[ Tue, Oct 09th 2012 ] - Market Wire
Interim Analysis Supports Continuation of Can-Fite's Phase 2/3 Psoriasis Clinical Study with CF101
[ Tue, Oct 09th 2012 ] - Market Wire
Cynosure To Host Third-Quarter 2012 Financial Results Conference Call On October 23
[ Tue, Oct 09th 2012 ] - Market Wire
Aethlon Medical to Present at the RedChip 15th Annual Small-Cap Conference on October 11th
[ Tue, Oct 09th 2012 ] - Market Wire
Boston Scientific Launches Victory Guidewire For Crossing Resistant Lesions In Peripheral Arteries
[ Tue, Oct 09th 2012 ] - Market Wire
Critical Outcome Technologies Inc. Achieves Important Milestone for AML Program
[ Tue, Oct 09th 2012 ] - Market Wire
Immunovaccine Reports Positive Interim Results fr .. of Ovarian Cancer Vaccine Candidate, DPX-Survivac
[ Tue, Oct 09th 2012 ] - Market Wire
Matrixx Initiatives Revises All-cash Acquisition Offer For ProPhase Labs
Mon, October 8, 2012
[ Mon, Oct 08th 2012 ] - Market Wire
Boston Scientific to Acquire Rhythmia Medical, Inc.
[ Mon, Oct 08th 2012 ] - Market Wire
Edwards Lifesciences Announces Preliminary Third Quarter 2012 Sales
[ Mon, Oct 08th 2012 ] - Market Wire
Boston Scientific To Announce Third-Quarter 2012 Financial Results On October 18th
[ Mon, Oct 08th 2012 ] - Market Wire
New Telit GPS Miniature Receiver Based on Latest .. mbedded Technology is Market’s Smallest
[ Mon, Oct 08th 2012 ] - Market Wire
Targacept Takes Further Actions to Align Resources with Corporate Objectives
[ Mon, Oct 08th 2012 ] - Market Wire
Dr. Reddy's Custom Pharmaceutical Services (CPS) .. ands Its Manufacturing Operations in Mirfield, UK
[ Mon, Oct 08th 2012 ] - Market Wire
Optimer Pharmaceuticals to Sell Remaining Ownersh .. Optimer Biotechnology, Inc. for U.S. $60 Million
[ Mon, Oct 08th 2012 ] - Market Wire
Revance Therapeutics Regains All Worldwide Rights to Its Botulinum Toxin Products
[ Mon, Oct 08th 2012 ] - Market Wire
AMILPAR - Associao Entre Amil e UnitedHealth Group
[ Mon, Oct 08th 2012 ] - Market Wire
AMILPAR - Association With UnitedHealth Group
[ Mon, Oct 08th 2012 ] - Market Wire
Lieff Cabraser Reminds Assisted Living Concepts, .. tors of Upcoming Deadline in Class Action Lawsuit
[ Mon, Oct 08th 2012 ] - Market Wire
Express Scripts Joins Qsymiaa" (Phentermine And T .. Release) Certified Home Delivery Pharmacy Network
[ Mon, Oct 08th 2012 ] - Market Wire
GTx to Present Scientific Poster Presentations on .. event and Treat Muscle Wasting in Cancer Patients
[ Mon, Oct 08th 2012 ] - Market Wire
NuPathe to Present at the Safeguard Scientifics Investor Day 2012
[ Mon, Oct 08th 2012 ] - Market Wire
UnitedHealth Group, Amil to Combine
[ Mon, Oct 08th 2012 ] - Market Wire
EXPAREL®; as the Foundation of a Multimoda .. l Significance in All Primary Endpoints, Includin
[ Mon, Oct 08th 2012 ] - Market Wire
Wright Medical Group, Inc. Announces Expiration of Deferred Prosecution Agreement
Sun, October 7, 2012
[ Sun, Oct 07th 2012 ] - Market Wire
Groundbreaking study shows that a simple, rapid P .. stratify pregnant women with suspected pre-eclamp
[ Sun, Oct 07th 2012 ] - Market Wire
Faruqi & Faruqi, LLP Encourages Investors Who Suf .. 0,000 Investing In Questcor Pharmaceuticals, Inc.
Sat, October 6, 2012
[ Sat, Oct 06th 2012 ] - Market Wire
Faruqi & Faruqi, LLP Encourages Investors Who Suf .. sting In Peregrine Pharmaceuticals, Inc. To Conta
[ Sat, Oct 06th 2012 ] - Market Wire
Rosen Law Firm Announces Investigation of China N .. Connection With Going Private Proposal from Kingb
[ Sat, Oct 06th 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. Losses Investing In Peregrine Pharmaceuticals, In
[ Sat, Oct 06th 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. cess of $100,000 Investing In Questcor Pharmaceut
Fri, October 5, 2012
[ Fri, Oct 05th 2012 ] - Market Wire
Health Net Federal Services, Penn State and Red C .. th Symposium for Physicians and Behavioral Health
[ Fri, Oct 05th 2012 ] - Market Wire
Watson Receives Approval from European Commission for Pending Actavis Acquisition
[ Fri, Oct 05th 2012 ] - Market Wire
Milberg LLP Announces Pendency of Class Action La .. e Pharmaceuticals, Inc. (PPHM) -- PeregrineLawsui
[ Fri, Oct 05th 2012 ] - Market Wire
Alliance HealthCare Services to Present at the De .. che Bank 20th Annual Leveraged Finance Conference
[ Fri, Oct 05th 2012 ] - Market Wire
Covance Inc. Invites You to Join the Webcast of I .. rd Quarter 2012 Financial Results Conference Call
[ Fri, Oct 05th 2012 ] - Market Wire
Fresenius Medical Care Recommends Seasonal Flu Shots for Dialysis Patients
[ Fri, Oct 05th 2012 ] - Market Wire
Hospira to Host Conference Call for Third-quarter 2012 Results
[ Fri, Oct 05th 2012 ] - Market Wire
Humana Bringing 200 New Jobs to Greater Cincinnati
[ Fri, Oct 05th 2012 ] - Market Wire
Rosen Law Firm Announces Investigation of Shengta .. n With Going Private Proposal from its Chairman a
[ Fri, Oct 05th 2012 ] - Market Wire
Ohr Pharmaceutical to Present at the 11th Annual BIO Investor Forum
[ Fri, Oct 05th 2012 ] - Market Wire
Amerigroup Foundation Presents 'Champion for Children' Award to Texas Representative John Zerwas
[ Fri, Oct 05th 2012 ] - Market Wire
Multiple miRNA Markers Associated with Angiogenes .. pair Expressed in Cytori’s Cell Therapy
[ Fri, Oct 05th 2012 ] - Market Wire
Cubist Announces Management Change
[ Fri, Oct 05th 2012 ] - Market Wire
Equity Research on HCA Holdings Inc. and Communit .. Healthcare Hospitals Taking the Good With the Bad
[ Fri, Oct 05th 2012 ] - Market Wire
The Law Firm of Wohl & Fruchter LLP Announces Investigation of Amyris, Inc.
[ Fri, Oct 05th 2012 ] - Market Wire
MannKind Completes Patient Recruitment in Two Phase 3 Clinical Studies of AFREZZA
[ Fri, Oct 05th 2012 ] - Market Wire
Boston Scientific ottiene l'approvazione della FD .. S-ICD pensato per i pazienti a rischio di arresto
Thu, October 4, 2012
[ Thu, Oct 04th 2012 ] - Market Wire
BARDA Exercises Contract Option as Emergent BioSo .. icant Progress in rPA Anthrax Vaccine Development
[ Thu, Oct 04th 2012 ] - Market Wire
Humana Awarded Contract to Manage Comprehensive M .. id Coverage for Residents in 16 Kentucky Counties
[ Thu, Oct 04th 2012 ] - Market Wire
Informational Seminars Set To Help Kentucky Retir .. Members Get Most From New Medicare Advantage Plan
[ Thu, Oct 04th 2012 ] - Market Wire
Sirona Biochem to Present Scientific Poster at Canadian Diabetes Professional Conference
[ Thu, Oct 04th 2012 ] - Market Wire
XTL Biopharmaceuticals Effectuates ADR Ratio Change
[ Thu, Oct 04th 2012 ] - Market Wire
Bio-Path Holdings Adds New Board Member
[ Thu, Oct 04th 2012 ] - Market Wire
RXi Pharmaceuticals Awarded NCI SBIR Funding to Advance Self-Delivering RNAi Technology
[ Thu, Oct 04th 2012 ] - Market Wire
Volcano annonce l'obtention du marquage CE et de .. de son nouveau cathter digital IVUS Visions PV .
[ Thu, Oct 04th 2012 ] - Market Wire
ERBA Diagnostics, Inc. Acquires Escalon Medical Corp. Clinical Diagnostics Business
[ Thu, Oct 04th 2012 ] - Market Wire
Durata Therapeutics Presenting Two Abstracts Concerning Dalbavancin at IDWeek 2012
[ Thu, Oct 04th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Presentation and Webcast at 11th Annual BIO Investor Forum
[ Thu, Oct 04th 2012 ] - Market Wire
Milestone Scientific Signs on Dental American Group
[ Thu, Oct 04th 2012 ] - Market Wire
Boston Therapeutics Wins FDA Approval to File an .. rug Application for PAZAMET(TM) to Treat Diabetes
[ Thu, Oct 04th 2012 ] - Market Wire
BioClinica, Inc. to Participate in Upcoming Indus .. obal Technology–Enhanced Clinical Trial
[ Thu, Oct 04th 2012 ] - Market Wire
New Caregiver Robots Poised to Change Elderly Lives
[ Thu, Oct 04th 2012 ] - Market Wire
Syneron destaca sus nuevos productos en la IMCAS Asia Meeting
Wed, October 3, 2012
[ Wed, Oct 03rd 2012 ] - Market Wire
Law Offices of Howard G. Smith Announces Class Ac .. on Lawsuit Against Questcor Pharmaceuticals, Inc.
[ Wed, Oct 03rd 2012 ] - Market Wire
Florida Blue Partners with Healthways to Offer Si .. neakers®;; Fitness Program Through 2015
[ Wed, Oct 03rd 2012 ] - Market Wire
Hologic to Release Fourth Quarter Fiscal 2012 Operating Results on Monday, November 12, 2012
[ Wed, Oct 03rd 2012 ] - Market Wire
Electrochem Offers Expanded Total Power Solutions; Retires Micro Power Brand
[ Wed, Oct 03rd 2012 ] - Market Wire
Antares Pharma Announces Pricing of Public Offering of Common Stock
[ Wed, Oct 03rd 2012 ] - Market Wire
Lpath Begins iSONEP Dosing in Nexus Phase 2 Study
[ Wed, Oct 03rd 2012 ] - Market Wire
Verastem to Present at BIO Investor Forum and Participate in Cancer Stem Cell Panel
[ Wed, Oct 03rd 2012 ] - Market Wire
Durata Therapeutics to Present at 11th Annual BIO Investor Forum
[ Wed, Oct 03rd 2012 ] - Market Wire
AcelRx Receives Notice of Eligibility for Central .. icines Agency for the Sufentanil NanoTab PCA Syst
[ Wed, Oct 03rd 2012 ] - Market Wire
Aeterna Zentaris Announces Share Consolidation to Regain NASDAQ Compliance
[ Wed, Oct 03rd 2012 ] - Market Wire
Market Influences That Drive Equities Forward - I .. rt on Abbott Laboratories and Glaxosmithkline Plc
[ Wed, Oct 03rd 2012 ] - Market Wire
Sarepta Therapeutics Receives Notice From Departm .. ense for Termination of Ebola Therapeutic Program
[ Wed, Oct 03rd 2012 ] - Market Wire
Sarepta Therapeutics Announces Eteplirsen Meets P .. Novel Dystrophin and Achieves Significant Clinica
[ Wed, Oct 03rd 2012 ] - Market Wire
Lorus Therapeutics to Present at BioContact 2012 in Quebec City
[ Wed, Oct 03rd 2012 ] - Market Wire
Health Management to Present at the Deutsche Bank 20th Annual Leveraged Finance Conference
[ Wed, Oct 03rd 2012 ] - Market Wire
St. Jude Medical's Peripheral Nerve Stimulation S .. dy Confirms Benefit for Chronic Migraine Patients
Tue, October 2, 2012
[ Tue, Oct 02nd 2012 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Peregrine Pharmaceuticals, Inc.
[ Tue, Oct 02nd 2012 ] - Market Wire
GreeneStone Supports the Cause of Mental Health with Charitable Foundation
[ Tue, Oct 02nd 2012 ] - Market Wire
Aeterna Zentaris Presented Poster on Oral Prostat .. 120, at International Urology Conference in Japan
[ Tue, Oct 02nd 2012 ] - Market Wire
RXi Pharmaceuticals to Present at 11th Annual BIO Investor Forum
[ Tue, Oct 02nd 2012 ] - Market Wire
NewLink to Present at 3rd Annual Cancer Immunotherapy Conference
[ Tue, Oct 02nd 2012 ] - Market Wire
LCA-Vision Reports Third Quarter 2012 Procedure Volume
[ Tue, Oct 02nd 2012 ] - Market Wire
Antares Pharma Receives Development Milestone Payment
[ Tue, Oct 02nd 2012 ] - Market Wire
Biostar Pharmaceuticals, Inc. To Manufacture And .. ply Xijing Military Hospital With Three New Drugs
[ Tue, Oct 02nd 2012 ] - Market Wire
DARA BioSciences Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule
[ Tue, Oct 02nd 2012 ] - Market Wire
Studies assess linagliptin treatment in adults wi .. (T2D), as well as add-on to basal insulin therapy
[ Tue, Oct 02nd 2012 ] - Market Wire
Lilly and Boehringer Ingelheim Present Health Out .. for Investigational Novel Basal Insulin Analogue
[ Tue, Oct 02nd 2012 ] - Market Wire
OncoSec Medical to Present at 3rd Annual Cancer Immunotherapy Conference
[ Tue, Oct 02nd 2012 ] - Market Wire
Life Technologies establece un nuevo estndar mundial con el kit GlobalFilera" Express
[ Tue, Oct 02nd 2012 ] - Market Wire
Department of Justice Drops DaVita Inquiry
[ Tue, Oct 02nd 2012 ] - Market Wire
NTRR Formulates Plan to Dramatically Reduce Global Alcohol Addiction
[ Tue, Oct 02nd 2012 ] - Market Wire
Medicure Announces Intention to Seek Expanded Aggrastat Label
Mon, October 1, 2012
[ Mon, Oct 01st 2012 ] - Market Wire
HealthSpring Unveils 2013 Medicare Advantage Plans with More Choices
[ Mon, Oct 01st 2012 ] - Market Wire
Luminex Corporation Participates in Community Initiatives to Save Lives
[ Mon, Oct 01st 2012 ] - Market Wire
Tenet Announces Four-Point Plan to Drive Shareholder Value Creation
[ Mon, Oct 01st 2012 ] - Market Wire
Extendicare Announces Exercise of Over-Allotment .. Closes on Lease of Remaining Two Kentucky Centers
[ Mon, Oct 01st 2012 ] - Market Wire
Care Improvement Plus Unveils 2013 Medicare Advantage Plans
[ Mon, Oct 01st 2012 ] - Market Wire
Horizon Pharma Announces Completion of Sales Force Expansion
[ Mon, Oct 01st 2012 ] - Market Wire
Implant Sciences Ships Explosives Trace Detectors .. to Protect Petroleum Infrastructure and Transport
[ Mon, Oct 01st 2012 ] - Market Wire
MethylGene Presents Clinical Data on MGCD265 at t .. Society for Medical Oncology (ESMO) 2012 Congress
[ Mon, Oct 01st 2012 ] - Market Wire
FONAR Reports Record Profits From Operations for .. me Doubles From Fiscal 2011;; Revenues Inc
[ Mon, Oct 01st 2012 ] - Market Wire
Bovie Medical to present at the 2012 SeeThruEquit .. p and Microcap Conference on Tuesday, October 2nd
[ Mon, Oct 01st 2012 ] - Market Wire
AVEO and Astellas Announce New Data Presented at .. ing the Safety and Tolerability Profile of Tivoza
[ Mon, Oct 01st 2012 ] - Market Wire
GTx Announces Sale of Fareston®;
[ Mon, Oct 01st 2012 ] - Market Wire
Syneron's elurea" Kicks Off the Break Up. Get Even! Campaign
[ Mon, Oct 01st 2012 ] - Market Wire
Sunshine Heart Announces Conditional Approval of .. E From the FDA for C-Pulse(R) Heart Assist System
[ Mon, Oct 01st 2012 ] - Market Wire
Millennium and Seattle Genetics Highlight Data fr .. imab Vedotin) Trial in Patients with Newly Diagno
[ Mon, Oct 01st 2012 ] - Market Wire
Could Stem Cells Hold the Key to Treating Traumatic Brain Injuries?
Sun, September 30, 2012
[ Sun, Sep 30th 2012 ] - Market Wire
Genomic Health anuncia la presentacin de tres estudios Oncotype DX sobre cncer de mama y colon
[ Sun, Sep 30th 2012 ] - Market Wire
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
[ Sun, Sep 30th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Preliminary D .. H-302 in Combination With Bevacizumab in Patients
[ Sun, Sep 30th 2012 ] - Market Wire
Interim Data for Cabozantinib 40 mg Dose Cohort i .. tant Prostate Cancer Presented at ESMO 2012 Congr
[ Sun, Sep 30th 2012 ] - Market Wire
Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012
Sat, September 29, 2012
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. tment-Naï;ve and Previously-Treated Metas
[ Sat, Sep 29th 2012 ] - Market Wire
Lilly Releases Phase II Results for Monoclonal Antibody Ramucirumab in Lung Cancer
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. Treatment-Naï;;ve and Previously-Treat
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. in Treatment-Naï;;;ve and Previous
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. umab) in Treatment-Naï;;;;ve and
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. limumab) in Treatment-Naï;;;;;
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. (ipilimumab) in Treatment-Naï;;;;
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. 59; (ipilimumab) in Treatment-Naï;;;
[ Sat, Sep 29th 2012 ] - Market Wire
ARIAD Presents Initial Clinical Proof-of-Concept .. Non-Small Cell Lung Cancer at ESMO 2012 Congress
[ Sat, Sep 29th 2012 ] - Market Wire
Updated Results from Phase 2b/3 GALAXY Trial Show .. vival from the Addition of Ganetespib to Docetaxe
[ Sat, Sep 29th 2012 ] - Market Wire
Exelixis Announces Data Presentation for GDC-0973 (XL518)
Fri, September 28, 2012
[ Fri, Sep 28th 2012 ] - Market Wire
Dehaier Medical Signed an Exclusive Distribution .. GCE Group, Europe's Leading Gas-equipment Company
[ Fri, Sep 28th 2012 ] - Market Wire
Biotech Industry Look to Benefit From the Introdu .. Technology Small Business Research Incentives Act
[ Fri, Sep 28th 2012 ] - Market Wire
Dynatronics Announces Fourth Quarter and Year-End Results
[ Fri, Sep 28th 2012 ] - Market Wire
Idera Pharmaceuticals to Present at the 3rd Annual Cancer Immunotherapy Conference
[ Fri, Sep 28th 2012 ] - Market Wire
Cytomedix Announces Poster Presentation at Britis .. thetic Plastic Surgeons Annual Scientific Meeting
[ Fri, Sep 28th 2012 ] - Market Wire
A.P. Pharma Resubmits New Drug Application for AP .. the Prevention of Chemotherapy-Induced Nausea an
[ Fri, Sep 28th 2012 ] - Market Wire
Where We Are Headed - New Outlook on Alere Inc. and PerkinElmer, Inc.
[ Fri, Sep 28th 2012 ] - Market Wire
Cytori Awarded Contract Valued up to $106 Million .. arch and Development Authority (BARDA) to Develop
[ Fri, Sep 28th 2012 ] - Market Wire
AVEO and Astellas Announce Submission of New Drug .. or the Treatment of Advanced Renal Cell Carcinoma
[ Fri, Sep 28th 2012 ] - Market Wire
Shareholder Rights Law Firm Johnson & Weaver, LLP .. uestcor Pharmaceuticals Inc. for Securities Fraud
[ Fri, Sep 28th 2012 ] - Market Wire
Swissmedic Invokes Rapid Authorization Procedures for Prochymal Review
[ Fri, Sep 28th 2012 ] - Market Wire
Oncolytics Biotech Inc. Announces the Appointment of Dr. Alan J. Tuchman as Chief Medical Officer
[ Fri, Sep 28th 2012 ] - Market Wire
call for signatures
[ Fri, Sep 28th 2012 ] - Market Wire
EYLEA (aflibercept) Injection Approved for the Tr .. of Wet Age-Related Macular Degeneration in Japan
[ Fri, Sep 28th 2012 ] - Market Wire
Boston Scientific Launches Vercisea" Deep Brain Stimulation System in Europe
[ Fri, Sep 28th 2012 ] - Market Wire
Unprecedented progression-free survival benefit w .. clinically meaningful improvements in life-limit
Thu, September 27, 2012
[ Thu, Sep 27th 2012 ] - Market Wire
30 a.m. Eastern
[ Thu, Sep 27th 2012 ] - Market Wire
Dynamic Energy Alliance to Present at Undiscovered Equities' New York Conference
[ Thu, Sep 27th 2012 ] - Market Wire
Positron To Present At The 1St International Busi .. roviders, Suppliers And Consumers In Moscow, Russ
[ Thu, Sep 27th 2012 ] - Market Wire
Teva Expands Central Nervous System (CNS) Develop .. n of Huntexil®; Development Program Rights
[ Thu, Sep 27th 2012 ] - Market Wire
Oral Arguments in the UCSF Appeal of United State .. Judgment in Favor of InSite Vision Are Scheduled
[ Thu, Sep 27th 2012 ] - Market Wire
BioLineRx Enters into Share Purchase Agreement with Lincoln Park Capital
[ Thu, Sep 27th 2012 ] - Market Wire
Peregrine Pharmaceuticals Announces New Location of Annual Meeting of Stockholders
[ Thu, Sep 27th 2012 ] - Market Wire
A Refreshing Outlook - Consensus Reports on UnitedHealth Group Incorporated and Health Net Inc.
[ Thu, Sep 27th 2012 ] - Market Wire
Horizon Pharma to Present at the 11th Annual BIO Investor Forum
[ Thu, Sep 27th 2012 ] - Market Wire
AspenBio Plans to Initiate Pivotal Study in Fourth Quarter
[ Thu, Sep 27th 2012 ] - Market Wire
Knome Introduces the knoSYS™100; Fi .. Plug-and-Play Human Genome Interpretation System
[ Thu, Sep 27th 2012 ] - Market Wire
BioLineRx Announces Publication of EAGLE Study Re .. Efficacy in Improving Cognitive Function in Schi
[ Thu, Sep 27th 2012 ] - Market Wire
Arnold C. Hanish Elected to Board of Directors of Omeros
[ Thu, Sep 27th 2012 ] - Market Wire
Provectus Expands Protocol for Phase 1 Liver Cancer Study
[ Thu, Sep 27th 2012 ] - Market Wire
Dr. Reddy’s Announces the Launch of Montelukast Sodium Oral Granules
[ Thu, Sep 27th 2012 ] - Market Wire
Syneron anuncia el lanzamiento global de Gentle P .. ual de la European Academy of Dermatology and Ven
Wed, September 26, 2012
[ Wed, Sep 26th 2012 ] - Market Wire
Robbins Umeda LLP Announces an Investigation of Masimo Corporation
[ Wed, Sep 26th 2012 ] - Market Wire
Forest Laboratories Submits New Drug Application .. an for the Treatment of Major Depressive Disorder
[ Wed, Sep 26th 2012 ] - Market Wire
Abattis to Complete Acquisition of FFE Assets &;; Domain Names
[ Wed, Sep 26th 2012 ] - Market Wire
RepliCel's Chief Medical Officer to Present at 21 .. of Dermatology &;; Venereology Congress

ImmunoCellular Therapeutics to Present at 3rd Annual Cancer Immunotherapy Conference and 2012 BIO Investor Forum


//health-fitness.news-articles.net/content/2012/ .. rapy-conference-and-2012-bio-investor-forum.html
Published in Health and Fitness on Tuesday, October 2nd 2012 at 13:17 GMT by Market Wire   Print publication without navigation


LOS ANGELES--([ ])--ImmunoCellular Therapeutics, Ltd. (aImmunoCellulara) (NYSE MKT: IMUC) today announced that Peter Ho, PhD, Director of Business Development, will present a company overview at 2:00 pm ET and participate in a panel discussion on advances in immunotherapy for glioma at 2:45 pm ET at the 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality conference on Thursday, October 4, 2012, at the New York Academy of Medicine.

A live and archived webcast of the company's presentation at the conference hosted by MD Becker Partners LLC will be available at [ www.regonline.com/mdb2012 ].

John S. Yu, MD, Interim Chief Executive Officer, will present a corporate overview and business update at the 11th Annual BIO Investor Forum on October 10, 2012 at 3:00 pm PT at the Palace Hotel, San Francisco, CA.

To access the live audio webcast of the BIO Investor Forum presentation, please log on through a link located in the Investor Relations section of ImmunoCellular's website at [ www.imuc.com ], under the Investors, Webcasts & Presentations tab. A replay of the webcasts will be available one hour after the conclusion of the live events.

About ImmunoCellular Therapeutics, Ltd.

ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular has commenced a Phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. To learn more about ImmunoCellular, please visit [ www.imuc.com ].


Publication Contributing Sources